Bb5a31f81ClaimA study in mice demonstrated that the consumption of kimchi led to a reduction in internal microplastic levelsAgreeDisagree
Bb5a31f81ClaimIn the Diabetes Prevention Program trial, an intensive lifestyle intervention was more effective than metformin at preventing type 2 diabetes in prediabetic individualsAgreeDisagree
Bb5a31f81ClaimIn an analysis of the Diabetes Prevention Program by Dr. Andres Cardenas, baseline PFAS levels predicted future incidence of obesity, type 2 diabetes, and hyperlipidemia in the control armAgreeDisagree
Bb5a31f81ClaimIn Dr. Andres Cardenas's analysis of the Diabetes Prevention Program, an intensive lifestyle intervention attenuated the disease risk associated with high baseline PFAS levelsAgreeDisagree
Bb5a31f81ClaimIn the CHAMACOS birth cohort study, childhood chemical exposures, including pesticides and persistent organic pollutants, were associated with decreases in child IQAgreeDisagree
Bb5a31f81ClaimA cholesterol-lowering human study found that consuming one gram of oat beta-glucan soluble fiber three times daily reduced circulating PFAS levelsAgreeDisagree
Bb5a31f81ClaimA study published in the American Chemical Society Journal showed that polymers from fenugreek and okra successfully removed plastics and plasticizers from waterAgreeDisagree
Bb5a31f81ClaimThe 10-year, $50 million TRAVERSE clinical trial assessed the cardiovascular and health outcomes of testosterone replacement therapy in 5,200 menAgreeDisagree
Bb5a31f81ClaimIn an Australian study, participants placed on a low-plastic protocol achieved an approximate 50 percent reduction in urinary phthalate and bisphenol levels within seven daysAgreeDisagree
Bb5a31f81ClaimIn a clinical trial conducted through UC San Diego and UCLA, co-administration of Agarikon and Turkey Tail mycelium with COVID-19 mRNA vaccines statistically significantly reduced adverse reactionsAgreeDisagree
Bb5a31f81ClaimA ketogenic dietary intervention studied by Virta Health reversed type 2 diabetes in 60 percent of participating patientsAgreeDisagree
Bb5a31f81ClaimThe Women's Health Initiative clinical trial evaluating hormone replacement therapy revealed that prior observational studies were confounded by healthy user biasAgreeDisagree
Bb5a31f81ClaimPatients treated with Merck and Moderna's experimental melanoma vaccine were less likely to develop distant metastatic recurrence than untreated trial participantsAgreeDisagree
Bb5a31f81ClaimIn psilocybin mushroom clinical trials, a standard therapeutic dose is commonly established at 25 milligrams of psilocybin or approximately 2.5 grams of dried Psilocybe cubensisAgreeDisagree
Bb5a31f81ClaimClinical trials conducted by Compass Pathways showed an approximately 40 to 45 percent response rate for psilocybin therapy in treatment-resistant depressionAgreeDisagree
Bb5a31f81ClaimClinical trial data over two years showed patients receiving Merck and Moderna's experimental melanoma vaccine were 42 percent less likely to experience cancer recurrence compared to patients who did not receive the vaccineAgreeDisagree
Bb5a31f81ClaimA clinical trial for Merck and Moderna's experimental melanoma vaccine enrolled more than 1,100 patients with stage 2, stage 3, or stage 4 melanomaAgreeDisagree
Bb5a31f81ClaimPatients who received Merck and Moderna's experimental melanoma vaccine reported mild side effects consisting of sore arms and flu-like symptoms lasting one to two daysAgreeDisagree
Bb5a31f81ClaimIn symptomatic, unvaccinated COVID-19 patients, treatment with Agarikon and Turkey Tail mycelium was associated with symptom resolution 5.1 days faster than placeboAgreeDisagree
Bb5a31f81ClaimPatients participating in Merck and Moderna's experimental melanoma vaccine clinical trial received nine doses administered once every three weeksAgreeDisagree